Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate (sUA) levels, ...
Majority of Participants Reached a Defined Threshold for Remission of Tardive Dyskinesia Regardless of Underlying Psychiatric Disorder <l ...
“The presentation of the updated DENALI Part 1b data at the SGO Annual Meeting supports our continued development of azenosertib,” said Ingmar Bruns, M.D., Chief Medical Officer ... is active in a ...
New Analyses Related to Aficamten Expand on its Metabolism Pathways,Treatment Effect Associated with Combination Therapy with Disopyramide<br ...
The growing adoption of 3D printing technology across various industries is driving a significant increase in the demand for specialized gases, including nitrogen, oxygen, and argon. In sectors ...
It’s simple: I perform oral on him, and that’s it. There’s no reciprocation, and we never talk about it afterward. In the ...
It seems the US Democratic Party has a new logo, or at least a new profile pic on social media. The design is instantly ...
Sharing photos, such as those featuring a child’s palm, can expose sensitive biometric data, such as fingerprints. Publicly ...
VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...
Operator Good day, and welcome to the FedEx third quarter fiscal 2025 earnings call. All participants are in listen-only mode ...
Recent advancements in endometriosis research are transforming treatment, focusing on non-surgical interventions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback